Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03138252 · ClinicalTrials.gov registry record · Phase 3
Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin
A Phase 3 study of Cervical Ripening and Induction of Labor, sponsored by University Hospitals Cleveland Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT03138252 is a Phase 3 study of Cervical Ripening and Induction of Labor that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 180 participants, below the 448-participant average among 8 other Cervical Ripening trials with a reported enrollment target (60% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03138252, a Phase 3 study of Cervical Ripening and Induction of Labor, has completed, sponsored by University Hospitals Cleveland Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
Study Purpose: The purpose of this study is to determine the optimal method for induction of labor in multiparous women who present with an unfavorable cervix. Hypothesis: Our hypothesis is that using oxytocin while the cervical ripening balloon is in place will result in more rapid labor courses, without increasing morbidity or increasing the need for operative delivery.
Conditions Studied
Interventions
- DRUG Oxytocin
Study Locations (1)
Ohio
- Alison Bauer - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2014-11 |
| Est. Completion | 2017-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03138252
The ClinicalTrials.gov registry entry for NCT03138252 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 448-participant average among 8 other Cervical Ripening trials with a reported enrollment target (60% lower). The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Cervical Ripening appearing as the primary indexed condition, and to 1 intervention - of which Oxytocin is the first listed.
NCT03138252 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT03138252 about?
NCT03138252 is a clinical study titled "Study of the Effectiveness of Cervical Ripening Balloon With and Without Oxytocin". Study Purpose: The purpose of this study is to determine the optimal method for induction of labor in multiparous women who present with an unfavorable cervix. Hypothesis: Our hypothesis is that using oxytocin while the cervical ripening balloon is in place will result in more rapid labor courses, ...
What is the current status of trial NCT03138252?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 180 participants. The study started on 2014-11. Estimated completion is 2017-07.
What conditions does trial NCT03138252 study?
This clinical trial studies the following conditions: Cervical Ripening, Induction of Labor, Multiparity.
What interventions are being tested in trial NCT03138252?
The interventions under investigation include: Oxytocin (DRUG).
Who is sponsoring clinical trial NCT03138252?
This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03138252 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Ripening
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy & Safety Study Comparing Misoprostol Vaginal Insert (MVI) Versus Dinoprostone Vaginal Insert (DVI) for Reducing Time to Vaginal Delivery
COMPLETED · Phase 3
-
Safety/Efficacy Study Comparing the Misoprostol Vaginal Insert to Cervidil for Cervical Ripening and Induction of Labor
COMPLETED · Phase 3
-
Patient Satisfaction During Outpatient Versus Inpatient Foley Catheter Induction of Labor
COMPLETED · NA
-
Foley Catheter Compared to the Foley Catheter Alone for Cervical Ripening
COMPLETED · NA
-
Misoprostol Vaginal Insert (MVI) 100, 150, 200 mcg for Cervical Ripening and Induction of Labor
COMPLETED · Phase 2
-
Pharmacokinetic (PK) Study of the 200 Microgram (mcg) Misoprostol Vaginal Insert (MVI 200) in Women at Term Gestation (The MVI-PK Study)
COMPLETED · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.